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Foster JD, Dunford C, Sillar KT, Miles GB. Nitric oxide-
mediated modulation of the murine locomotor network. J Neuro-
physiol 111: 659–674, 2014. First published November 20, 2013;
doi:10.1152/jn.00378.2013.—Spinal motor control networks are reg-
ulated by neuromodulatory systems to allow adaptability of move-
ments. The present study aimed to elucidate the role of nitric oxide
(NO) in the modulation of mammalian spinal locomotor networks.
This was investigated with isolated spinal cord preparations from
neonatal mice in which rhythmic locomotor-related activity was
induced pharmacologically. Bath application of the NO donor dieth-
ylamine NONOate (DEA/NO) decreased the frequency and modu-
lated the amplitude of locomotor-related activity recorded from ven-
tral roots. Removal of endogenous NO with coapplication of a NO
scavenger (PTIO) and a nitric oxide synthase (NOS) blocker [nitro-
L-arginine methyl ester (L-NAME)] increased the frequency and
decreased the amplitude of locomotor-related activity. This demon-
strates that endogenously derived NO can modulate both the timing
and intensity of locomotor-related activity. The effects of DEA/NO
were mimicked by the cGMP analog 8-bromo-cGMP. In addition, the
soluble guanylyl cyclase (sGC) inhibitor ODQ blocked the effects of
DEA/NO on burst amplitude and frequency, although the frequency
effect was only blocked at low concentrations of DEA/NO. This
suggests that NO-mediated modulation involves cGMP-dependent
pathways. Sources of NO were studied within the lumbar spinal cord
during postnatal development (postnatal days 1–12) with NADPH-
diaphorase staining. NOS-positive cells in the ventral horn exhibited
a rostrocaudal gradient, with more cells in rostral segments. The
number of NOS-positive cells was also found to increase during
postnatal development. In summary, we have shown that NO, derived
from sources within the mammalian spinal cord, modulates the output
of spinal motor networks and is therefore likely to contribute to the
fine-tuning of locomotor behavior.
spinal cord; neuromodulation; central pattern generator; motor control
ALTHOUGH AT ITS CORE vertebrate locomotion involves rhythmic,
stereotyped contractions of muscles, locomotor behavior must
also be flexible so that it can be adjusted to suit changing
environmental and developmental demands. The ability to
produce rhythmic activity needed for locomotion is an inherent
property of the spinal cord. The spinal motor network that
produces this rhythm is termed the locomotor central pattern
generator (CPG). The locomotor CPG is in turn regulated by a
range of neuromodulatory systems that enable locomotor out-
put to be adaptable (Miles and Sillar 2011). These modulatory
inputs to the locomotor CPG can originate from either extrinsic
sources, such as noradrenergic and serotonergic systems of the
brain stem (as reviewed by Heckman et al. 2009; Rekling et al.
2000), or intrinsic sources within the spinal cord, for example,
those utilizing adenosine (Witts et al. 2012), acetylcholine
(Zagoraiou et al. 2009), and nitric oxide (NO) (Kyriakatos et
al. 2009).
The gaseous neurotransmitter NO is a lipophilic free radical
molecule with a short life span that is released when L-arginine
is oxidized to L-citrulline by the enzyme nitric oxide synthase
(NOS). Three isoforms of NOS have been identified (NOS1,
nNOS; NOS2, iNOS; NOS3, eNOS), with the function of two
of these variants, NOS1 and NOS3, being activity dependent
because of their requirement for calcium/calmodulin binding.
NO typically acts via the stimulation of soluble guanylyl
cyclase (sGC) to increase intracellular levels of cGMP, which
can act upon a range of intracellular and membrane-bound
proteins (Ahern et al. 2002). However, additional mechanisms
of action for NO exist, including S-nitrosylation of proteins and
the generation of reactive oxygen species. It was first shown
that NO produced by the endothelium, via NOS3, is essential
for maintaining vascular tone (Huang et al. 1995; Shesely et al.
1996). It has also been shown that NOS3 activity provides a
basal level of NO needed for the generation of hippocampal
long-term potentiation (LTP), which is mediated by the addi-
tional release and summation of neuronally derived NO
(O’Dell et al. 1994; Son et al. 1996). Furthermore, since NO
can freely diffuse across biological membranes it can act as a
volume transmitter to provide slow modulatory signals to both
active and inactive neurons across whole neuronal networks
(Steinert et al. 2008).
Previous investigations have shown that NO-mediated sig-
naling has a marked neuromodulatory effect on spinal motor
networks that generate the axial-based swimming movements
of both Xenopus tadpoles (McLean and Sillar 2000, 2004) and
lampreys (Kyriakatos et al. 2009; Kyriakatos and El Manira
2007). In the Xenopus tadpole, NO synthesized by a discrete
cluster of neurons within the brain stem acts as an inhibitory
extrinsic neuromodulator reducing the cycle frequency of
swimming activity (McLean and Sillar 2000). During later
developmental stages in Xenopus, when limbs and presumably
their spinal control circuitry develop, NOS-expressing cells are
also present in the spinal cord (Ramanathan et al. 2006). At
these later stages NO may act as an intrinsic modulator of
locomotion that, in contrast to early stages, increases the
frequency of locomotor activity (Sillar et al. 2008). Several
classes of spinal neurons in the adult lamprey have been
demonstrated to express NOS (Kyriakatos et al. 2009). In
lamprey spinal cord preparations, NO donors potentiate loco-
motor frequency while NOS inhibitors/NO scavengers de-
crease the frequency of locomotion, demonstrating an endog-
enous role for NO (Kyriakatos et al. 2009). In addition, NOS
inhibitors occlude the LTP of locomotor frequency induced by
activation of metabotropic glutamate receptors (Kyriakatos and
El Manira 2007).
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While the role of NO in the spinal locomotor circuitry of
aquatic vertebrates is relatively well-defined, the role of NO in
the control of mammalian locomotion has not previously been
investigated despite evidence of considerable sources of NO in
the mammalian spinal cord (Blottner and Baumgarten 1992;
Burnett et al. 1995; Dun et al. 1993; Spike et al. 1993;
Valtschanoff et al. 1992; Wetts et al. 1995). A modulatory role
for NO has, however, been demonstrated for another rhythmic
motor behavior in mammals, respiration, which is controlled
by a brain stem CPG network. In rodents, NO donors appear to
reduce the frequency and amplitude of spontaneous respiratory
motor output while NOS inhibitors produce the opposite effect,
indicating neuromodulation by endogenous NO (Mironov and
Langohr 2007; Pierrefiche et al. 2007). These findings demon-
strate that NO can modulate rhythmic motor activity produced
by a mammalian CPG network. Our study therefore aimed to
investigate whether NO plays a modulatory role within the
mammalian spinal locomotor network, as has been shown for
aquatic vertebrates. We demonstrate that NO, derived from
sources within the spinal cord, modulates the output of spinal
locomotor control circuitry in mice. Furthermore, we identify
potential sources of this intrinsic, neuromodulatory NO and
describe their postnatal development.
METHODS
Tissue preparation. The use of animals in this investigation was in
accordance with the United Kingdom Animals (in Scientific Proce-
dures) Act 1986 and was reviewed and approved by the University of
St Andrews Animal Welfare and Ethics Committee. For physiological
preparations spinal cord tissue was prepared from postnatal day
(P)2–P5 C57BL/6 mice, as described previously (Jiang et al. 1999). In
brief, animals were killed by cervical dislocation, decapitated, and
eviscerated before a section of the spinal cord extending from the
midthoracic to upper sacral levels was isolated in a chamber contain-
ing artificial cerebrospinal fluid (aCSF; equilibrated with 95% O2-5%
CO2, at room temperature). Isolated tissues were pinned down and the
dorsal and ventral roots trimmed. Prepared tissues were then trans-
ferred to a recording chamber superfused with aCSF with a flow rate
of 5–8 ml/min. For histological analyses spinal cord tissue was
prepared from P1–P12 C57BL/6 or CD1 mice, as described above for
physiological preparations, and tissues were then fixed via submersion
in 4% paraformaldehyde (wt/vol) in 0.1 M phosphate buffer (PB; pH
7.4) for 12 h. The aCSF used for both dissections and recordings
contained (in mM) 127 NaCl, 26 NaHCO3, 10 glucose, 3 KCl, 2 CaCl,
1.25 NaH2PO4, and 1 MgCl2.
Ventral root recordings. Glass suction electrodes were attached to
the first or second lumbar ventral roots (L1/L2), to record flexor-
related activity, on both left and right sides at identical segmental
levels of isolated spinal cord preparations (obtained from P2–P5
C57BL/6 mice). In a subset of experiments, extensor-related activity
was also recorded from the fifth lumbar ventral root (L5). Rhythmic
locomotor-related activity, alternating between contralateral upper
lumbar roots and ipsilateral L2 and L5 roots, was induced pharmaco-
logically with a combination of N-methyl-D-aspartic acid (NMDA, 5
M) and 5-hydroxytryptamine (5-HT, 10 M), with or without
dopamine (50 M). The inclusion of dopamine was associated with
lower burst frequencies in control (with dopamine: 0.192 0.019 Hz,
n  17; without dopamine: 0.246  0.011 Hz, n  38; Student’s
t-test, P  0.05). However, statistical analyses demonstrated that the
effects of subsequent drug applications did not differ between prep-
arations with and without dopamine. For experiments investigating
the importance of excitatory versus inhibitory components of the
network we utilized a disinhibited preparation (Bracci et al. 1996) in
which strychnine (1 M) and either bicuculline (10 M) or picrotoxin
(60 M) was added to block inhibitory transmission. This resulted in
synchronous activity across contralateral roots. Activity recorded with
bicuculline or picrotoxin did not differ; therefore preparations using
either drug were grouped together for analyses [peak-to-peak ampli-
tude: bicuculline 5.9  0.9 a.b. (n  16), picrotoxin: 6.2  1.0 a.b.
(n  14), Student’s t-test, P  0.05; root-mean-squared (RMS)
amplitude: bicuculline 0.48  0.07 a.b. (n  16), picrotoxin: 0.50 
0.08 a.b. (n  14), Student’s t-test, P  0.05; frequency: bicucul-
line 0.061  0.004 Hz (n  16), picrotoxin: 0.054  0.004 Hz (n 
14), Student’s t-test, P  0.05]. Subsequent drug applications were
made once the bursts of locomotor-related activity recorded from
ventral roots had stabilized (1 h; Witts et al. 2012). Drug washout
was achieved via perfusion with drug-free aCSF. Data were amplified
and filtered (band-pass filter 30–3,000 Hz; Qjin Design) and acquired
at a sampling frequency of 6 kHz with a Digidata 1440A analog-to-
digital converter and Axoscope software (Molecular Devices, Sunny-
vale, CA). Custom-built amplifiers (Qjin Design) also allowed for the
simultaneous online rectification and integration (50-ms time con-
stant) of raw signals.
Data analysis. Data were analyzed off-line with DataView soft-
ware (courtesy of Dr. W. J. Heitler, University of St Andrews).
Rectified/integrated traces were used for the detection of locomotor-
related ventral root bursts. The instantaneous frequencies, peak-to-
peak amplitudes, and RMS amplitudes (for disinhibited preparations)
of ventral root bursts were then measured from raw traces. Amplitude
was measured as a noncalibrated unit and is therefore presented as an
arbitrary unit (a.b.). For time course plots data were aggregated into
1-min bins, or 2-min bins for disinhibited preparations, and normal-
ized to a 10-min precontrol period to facilitate comparison between
preparations. To calculate burst duration, individual bursts from a
10-min smoothed trace (4 iterations of 200 ms moving average) were
downsampled to 100 Hz and the duration of each burst (the time taken
from 40% peak amplitude on the upstroke to 40% peak amplitude on
the downstroke) was calculated with a custom “R” script. Duty cycle
was calculated as burst duration divided by cycle period. Statistical
comparisons of burst amplitude and frequency were performed on
absolute means, calculated over 5-min periods for standard prepara-
tions and 6-min periods for disinhibited preparations, for control, drug
application, and washout phases. Data were analyzed with repeated-
measures ANOVA and pairwise comparison with a Tukey’s honestly
significant difference (HSD) test, with P values  0.05 taken as
significant. Divergence of the data from sphericity was tested and
Greenhouse-Giesser corrections applied where necessary. Repeated-
measure ANOVAs and circular plot analyses were performed with
“R” and the software packages “car” and “circular,” respectively. All
data are presented as means  SE.
The phase relationship between activity recorded from different
pairs of ventral roots was assessed with circular plots and Rayleigh’s
test for uniformity (Kjaerulff and Kiehn 1996; Zagoraiou et al. 2009).
Comparisons between the left-right and flexor-extensor phase rela-
tionships in control and drug conditions were made with the Watson-
Williams test of homogeneity of means. In circular plots of left-right
phase relationships, the “0” label denotes the timing of left ventral
root bursts (at their peak amplitude) while individual data points
denote the mean phase of right ventral root bursts (100 bursts) in
single preparations, with their distance from the center indicating the
concentration of values around the mean (mean resultant vector). For
circular plots of flexor-extensor phase relationships, the “0” label
denotes the timing of flexor-related (L2) ventral root bursts (at their
peak amplitude) while the individual data points indicate the mean
phase of ipsilateral extensor-related (L5) root bursts (at their center of
mass, 70 bursts). Center of mass, defined as the time point at which
the voltage reached half of its cumulative summed total, was chosen
for the L5 bursts because of the elongated shape of their extensor-
related activity. Arrows associated with the circular plots indicate the
mean direction of the phase relationships across all preparations
analyzed.
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NADPH-diaphorase histochemistry and cell counting. After fixa-
tion, lumbar segments (1st to 5th) were cryoprotected in 30% sucrose
(wt/vol) in PB at 4°C for 12 h and then frozen and stored at 20°C
until being sectioned. Tissues were cut into 10- to 15-m transverse
sections on a cryostat and mounted on glass slides. Slides were
incubated at 37°C with 1 mg/ml -NADPH, 0.13 mg/ml nitro blue
tetrazolium (NBT), and 0.3% Triton X-100 (vol/vol) in 0.1 M phos-
phate-buffered saline (PBS; pH 7.4) for 110 min and then washed in
PBS to halt the reaction. In the presence of NOS and NADPH, NBT
is reduced to the alcohol-insoluble blue dye nitro blue tetrazolium
formazan, thereby indirectly labeling NOS-expressing cells for visu-
alization under light microscopy (McLean and Sillar 2000).
Animals were categorized by age into four equally spaced groups
(P1–P3, P4–P6, P7–P9, and P10–P12). With reference to Rexed’s
laminae, the dorsal horn was defined as lamina I–VI, the ventral horn
as lamina VII–IX, and the area proximal to the central canal as lamina
X. For each animal, images of five nonconsecutive (separated by at
least 30 m) spinal cord slices were obtained for each lumbar segment
of interest. The number of positively stained cells in the dorsal horn,
lamina X, and ventral horn were then counted manually. Although
both C57BL/6 (n  3) and CD1 (n  24) mouse strains were used for
histological analyses, no differences in the distribution of NADPH-
diaphorase-positive cells were observed between the two strains.
Given that the density of spinal neurons reduces developmentally, we
adjusted cell counts to account for changes in lumbar spinal cord
volume with age. The volume of the lumbar spinal cord was calcu-
lated from measurements of fixed spinal cord tissue (P1–P3, n  5;
P4–P6, n  7; P7–P9, n  6; P10–P12, n  6). Lumbar volume
estimates were calculated as the volume of a cylinder using the mean
spinal cord diameter at L1, L3, and L5 and the mean length between L1
and L5 (P1–P3: 6.36  0.45 mm3; P4–P6, 6.96  0.35 mm3; P7–P9,
8.30  0.12 mm3; P10–P12, 9.52  0.13 mm3). With “R” and the
package “MASS,” count data were fitted with a negative binomial
generalized linear model using age and lumbar position as factors and
log volume as an offset term (thereby fitting the model to counts per
mm3 of volume). The influence of the factors age and lumbar position
were assessed with likelihood ratio tests.
Immunohistochemistry. Two days prior to experimentation CD1
mice received an intraperitoneal injection of Fluoro-Gold [40 mg/kg
hydroxystilbamidine (Fluoro-Gold); Fluorochrome, Denver, CO] to
retrogradely label sympathetic preganglionic neurons (SPNs) (Mer-
chenthaler 1991). Spinal cords from these mice were dissected and
fixed for 2 h, as described above, and stored in PBS at 4°C until being
sectioned. Lumbar spinal slices at the L1–L2 level were cut at a
thickness of 50 m on a vibratome, and free-floating sections were
incubated for 24 h at 4°C with rabbit primary antibodies raised against
NOS1 (5 g/ml; SAB43000426; Sigma-Aldrich, Poole, UK) in PBS
with 1% bovine serum albumin (wt/vol) and 0.1% Triton X-100
(vol/vol). Bound primary antibody was labeled with fluorescein iso-
thiocyanate (FITC)-tagged donkey anti-rabbit secondary antibody (3
g/ml; 711-095-152; Jackson Immuno Research Laboratories, West
Grove, PA) during a 2-h incubation. Z-plane optical sections of the
stained tissue were created with an epifluorescence microscope and
structured illumination (Imager.M2 fitted with Apotome.2, Carl Zeiss
Microscopy, Göttingen, Germany), and the images were processed
into a maximum Z projection (ImageJ; National Institutes of Health,
Bethesda, MD).
Drug and solution preparation. The NO donor diethylamine
NONOate (DEA/NO) was supplied by Cambridge Bioscience (Cam-
bridge, UK). The cGMP-dependent protein kinase activator 8-bromo-
cGMP was obtained from Tocris Bioscience (Bristol, UK). The NOS
inhibitor nitro-L-arginine methyl ester (L-NAME), the sGC inhibitor
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), and 5-HT were
obtained from Abcam (Cambridge, UK). All other reagents were of
analytical grade and supplied by either Fisher Scientific UK (Lough-
borough, UK) or Sigma-Aldrich. All drugs were dissolved in reverse
osmosis water, except 2-phenyl-4,4,5,5-tetramethylimidazoline-1-
oxyl 3-oxide (PTIO) and ODQ, which were dissolved in DMSO, and
stored in aliquots at 20°C. Final concentration of DMSO in the
working solutions was 0.1% (vol/vol).
RESULTS
Nitric oxide-mediated signaling modulates spinal locomotor
circuitry. To investigate whether NO-mediated signaling can
modulate the activity of spinal motor networks controlling mam-
malian locomotion, we bath applied the NO donor DEA/NO at a
range of concentrations (50 M, n 15 preparations; 100 M,
n  13; 200 M, n  17; 400 M, n  10) to isolated spinal
cord preparations while recording pharmacologically induced
fictive locomotor activity from ventral roots (Fig. 1A). At all
concentrations investigated, DEA/NO caused a reversible de-
crease in the frequency of bursts of locomotor-related ventral
root activity (13.9  6.1% decrease with 50 M, 21.1  7.5%
decrease with 100 M, 28.4  6.0% decrease with 200 M,
and 57.6 7.3% decrease with 400 M; Fig. 1, Ai, Aii, Ci, Cii,
and Dii). The modulatory effects of DEA/NO on the frequency
of the locomotor rhythm were concentration dependent (Fig.
1Dii; DEA/NO concentration: F[3,50]  7.9, P  0.001;
control/drug/wash: F[2,100]  4.9, P  0.01; interaction:
F[6,100]  4.7, P  0.001, n  10–17), with a maximum
reduction observed at a dose of 400 M. Given the variability
in control frequencies of different preparations, we investi-
gated whether there was a relationship between the starting
frequency and the magnitude of the effect induced by DEA/
NO; however, no significant relationship was identified.
In a subset of experiments we also assessed the effects of
DEA/NO on burst duration and duty cycle. Burst duration was
unchanged at all concentrations of DEA/NO (pooled mean for
all DEA/NO concentrations: control 1.74  0.04 s, DEA/NO
1.99  0.09 s, washout 1.78  0.08 s, n  32 pooled;
DEA/NO concentration: F[3,28]  1.4, P  0.05; control/
drug/wash: F[2,56]  1.2, P  0.05; interaction: F[6,56] 
0.1, P  0.05, n  7–10 per DEA/NO concentration). Duty
cycle was found to decrease with 200 M and 400 M
DEA/NO (19.8  6.7% decrease with 200 M and 29.3 
5.2% decrease with 400 M; DEA/NO concentration: F[3,28] 
4.5, P  0.05; control/drug/wash: F[2,56]  0.6, P  0.05;
interaction: F[6,56]  4.6, P  0.001, n  7–10), but no
significant change was observed with lower concentrations (50
M, n  7; 100 M, n  10).
DEA/NO also induced a concentration-dependent change in
the amplitude of locomotor-related ventral root bursts (Fig.
1Di; DEA/NO concentration: F[3,50] 3.5, P 0.05; control/
drug/wash: F[2,100]  4.5, P  0.05; interaction: F[6,100] 
4.1, P  0.001, n  10–17). In contrast to the consistent
reduction in burst frequency, the polarity of the effect of
DEA/NO on burst amplitude was concentration dependent. At
higher concentrations (200 and 400 M) DEA/NO caused a
reduction in burst amplitude (8.4  2.5% decrease with 200
M, 10.4  2.1% decrease with 400 M; Fig. 1, Aii, Cii, and
Di). However, at lower concentrations the application of
DEA/NO either had no effect (100 M; Fig. 1Di) or led to an
increase in burst amplitude (7.8  2.3% increase with 50 M;
Fig. 1, Ai, Ci, and Di). While the reduction in burst amplitude
induced by high concentrations of DEA/NO was reversible, the
increase in burst amplitude induced by 50 M DEA/NO
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remained after drug washout and persisted for the duration of
stable recordings (up to 60 min after initiation of washout).
Control experiments in which no drugs were applied (beyond
those used to elicit locomotor activity) demonstrated that
locomotor burst amplitude is typically stable over a similar
time course (n  7; data not shown).
While the frequency, amplitude, and duty cycle of locomo-
tor-related activity were modulated by DEA/NO, mean phase
relationships of left-right (contralateral upper lumbar roots)
and flexor-extensor (L2 vs. L5 ipsilateral roots) alternation
remained unaltered (left-right phase, control: 0.492  0.004,
DEA/NO: 0.503  0.009, n  6; flexor-extensor phase, con-
Ai Control DEA/NO [50 μM] Wash
L2 L Raw 
L2 R Raw 
ʃL2 L
ʃL2 R



















662 NO-MEDIATED MODULATION OF MURINE LOCOMOTOR NETWORK
J Neurophysiol • doi:10.1152/jn.00378.2013 • www.jn.org
o
n





trol: 0.450  0.029, DEA/NO: 0.399  0.031, n  6). This
was demonstrated by circular phase plots in which the mean
direction of left-right (100 bursts analyzed in control and
drug conditions; Fig. 1Bi; Watson-Williams test, F[1,10] 
0.2, P 0.05, n 6) and flexor-extensor (70 bursts analyzed
in control and drug conditions; Fig. 1Bii; Watson-Williams
test, F[1,10]  1.5, P  0.05, n  6) alternation was un-
changed by the application of DEA/NO (50–200 M DEA/
NO). The mean resultant length of the vectors for both left-
right and flexor-extensor relationships was found to decrease in
the presence of DEA/NO (L2 left/right relationship: control
0.87, DEA/NO 0.65; L2/L5 relationship: control 0.80, DEA/NO
0.67), demonstrating an increase in the variability of the phase
relationships. This reduction in the strength of phase relation-
ships is likely to result from an increase in the variability of
locomotor output as revealed by greater coefficients of varia-
tion for frequency during the application of DEA/NO at all
concentrations tested [50 M: 0.138  0.007 (control) vs.
0.245  0.027 (DEA/NO); 100 M: 0.194  0.032 (control)
vs. 0.379  0.048 (DEA/NO); 200 M: 0.143  0.020
(control) vs. 0.362  0.057 (DEA/NO); 400 M: 0.152 
0.040 (control) vs. 0.483  0.055 (DEA/NO); DEA/NO con-
centration: F[3,28]  4.2, P  0.05; control/drug/wash: F[2,56] 
2.6, P  0.05; interaction: F[6,56]  5.9, P  0.001, n 
7–10].
In summary, these data demonstrate that NO-mediated signal-
ing can modulate both the frequency and intensity of locomotor-
related output generated by spinal motor circuitry. Thus NO may
have multiple cellular sites of action including rhythm-generating
interneurons and motoneurons. Interestingly, at lower concentra-
tions, NO induces longer-term enhancement of the amplitude of
locomotor network output.
Endogenous nitric oxide modulates locomotor network activity.
Next we investigated whether NO-mediated modulation repre-
sents an endogenous mechanism utilized by spinal cord cir-
cuitry to control locomotor output. To investigate the potential
role of endogenous NO in the modulation of the murine
locomotor network, we coapplied the NO scavenger PTIO (400
M) and the NOS inhibitor L-NAME (200 M) while record-
ing fictive locomotion from isolated spinal cord preparations.
When L-NAME and PTIO were coapplied to reduce the
amount of endogenous NO available, we observed a decrease
in the amplitude of locomotor-related ventral root bursts (7.7
2.2%; Fig. 2, A, B, and Ci; F[3,18]  11.8, P  0.001, n  8).
Interestingly, the washout of L-NAME and PTIO was associ-
ated with an increase in amplitude during an extended washout
period (18.7  4.8% increase compared with control, n  7).
The similarity between this increase and the long-term effects
of 50 M DEA/NO application suggest that it may relate to a
rebound in endogenous NO levels following the washout of
blockers/scavengers. The coapplication of L-NAME and PTIO
also led to an increase in the frequency (20.4 2.4%; Fig. 2, A, B,
and Cii; F[3,18]  3.2, P  0.05, n  8) of locomotor-related
activity. There was again no relationship between control
frequency and the magnitude of frequency effects induced by
L-NAME and PTIO. These findings demonstrate that NO is
produced by the spinal cord during locomotor network activity.
Furthermore, this endogenous NO modulates locomotor con-
trol circuitry to regulate the frequency and intensity of loco-
motor-related output.
Nitric oxide-mediated modulation involves the cGMP-de-
pendent pathway. NO-mediated signaling typically involves
the activation of NO-sensitive sGC and the subsequent accu-
mulation of intracellular cGMP that can act on a range of
intracellular and membrane-bound targets (Ahern et al. 2002).
To elucidate the signaling pathways involved in NO-mediated
modulation of spinal locomotor circuitry, we assessed the
effects of pharmacological agents that target sGC-mediated
signaling pathways. We first investigated the effects of appli-
cation of a stable and membrane-permeant analog of cGMP,
8-bromo-cGMP (200 M), on locomotor-related activity re-
corded from the isolated spinal cord preparation. The applica-
tion of 8-bromo-cGMP led to a reversible reduction in the
frequency of locomotor-related activity (24.9  5.6%; Fig. 3, A, B,
and Cii; F[2,16]  16.3, P  0.001, n  9) and a sustained
increase in the amplitude of locomotor-related ventral root
bursts (8.9  2.6%; Fig. 3, A, B, and Ci; F[2, 16]  8.4, P 
0.01, n  9). The actions of 8-bromo-cGMP mimic the effects
of the lower concentration of DEA/NO (50 M; Fig. 1, Ai, Ci,
Di, and Dii) and support involvement of the sGC/cGMP
pathway in the modulatory actions of NO on the murine
locomotor control network.
To further elucidate the role of the sGC/cGMP pathway we
next applied DEA/NO (50 or 200 M) in the presence of the
sGC blocker ODQ (100 M). The effects of both 50 and 200
M DEA/NO on the amplitude of locomotor-related activity
were blocked by ODQ (100 M; DEA/NO 50 M: F[2,12] 
1.8, P  0.05, n  7, data not shown; DEA/NO 200 M:
F[2,22]  2.3, P  0.05, n  12, Fig. 4, B and Ci). ODQ also
blocked the reduction in frequency induced by 50 M (F[2,12] 
1.8, P  0.05, n  7; data not shown) but not 200 M (Fig. 4,
A, B, and Cii; F[2,22]  7.9, P  0.05, n  12) DEA/NO.
Comparison of the percent change in frequency induced by
DEA/NO (200 M) with and without ODQ (100 M) showed
no difference in the magnitude of this effect (Student’s t-test,
P  0.05). At higher concentrations of ODQ (200 M, n  6;
data not shown) the locomotor rhythm became unstable or
ceased, so we could not test the possibility that 100 M
ODQ was an insufficient concentration to block the effects
of 200 M DEA/NO on locomotor frequency. Together
Fig. 1. The nitric oxide (NO) donor diethylamine NONOate (DEA/NO) decreases the frequency and modulates the amplitude of locomotor-related activity in
a concentration-dependent manner. A: raw (top) and rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral roots and the left (L) L5
ventral root (Ai) or both L2 ventral roots without L5 (Aii), showing the effects of 50 M (Ai) and 200 M (Aii) DEA/NO. B: circular plots displaying mean
left-right phase relationships (Bi) in individual preparations (100 bursts for each L2 root; 200 M DEA/NO) or flexor-extensor phase relationships (Bii; 70
bursts for each root; 50–200 M DEA/NO), with circles denoting measurements during control periods and crosses denoting those during DEA/NO application
(n  6 preparations). No change was identified between left-right or flexor-extensor phasing in control and drug conditions (P  0.05). Ci: pooled time course
plot of normalized data aggregated into 1-min bins shows an increase in amplitude (top) and a decrease in frequency (bottom) during 50 M DEA/NO application
(n  15). Cii: time course plot during application of 200 M DEA/NO shows a decrease in both normalized amplitude (top) and frequency (bottom) (n  17).
D: % change in locomotor burst amplitude (Di) and frequency (Dii), in response to varying concentrations of DEA/NO, calculated by comparing the last 5 min
of control with a 5-min period during DEA/NO applications of varying concentrations. Statistically significant difference from control period: *P  0.05,
**P  0.01, ***P  0.001; n  10–17.
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these findings further support the idea that NO-mediated
modulation of the intensity of locomotor output generated
by spinal CPG circuitry involves the sGC/cGMP path-
way.
NO-mediated modulation involves both excitatory and in-
hibitory components of the locomotor CPG. To begin to
explore the spinal components involved in NO-mediated mod-
ulation of locomotor control circuitry, we utilized disinhibited
preparations (Bracci et al. 1996) to pharmacologically dissect
out the effects of NO-mediated signaling on inhibitory and
excitatory components of the network (Witts et al. 2012).
Disinhibited preparations were produced by blocking inhibi-
tory transmission with the glycine receptor antagonist strych-
nine (1 M) and the GABAA receptor antagonist bicuculline
(10 M) or the GABAA channel blocker picrotoxin (60 M).
Ventral root recordings from these preparations revealed slow,
rhythmic, large-amplitude bursts that were synchronous across
segmentally aligned left and right ventral roots (Fig. 5A and
Fig. 6A). In keeping with experiments performed in standard
preparations, removal of endogenous NO, by coapplication of
L-NAME and PTIO, in disinhibited preparations led to an
increase in the frequency of locomotor-related ventral root
bursts (26.7  5.9%; Fig. 5, A, B, and Cii; F[2,16]  11.8,
P 0.001, n 9). However, L-NAME and PTIO had no effect
on the peak-to-peak amplitude of locomotor-related bursts in
disinhibited preparations (Fig. 5, A, B, and Ci; F[2,16]  1.3,
P  0.05, n  9). Given the irregular shape of disinhibited
bursts, with a sharp peak followed by a lower-amplitude
plateau, we also utilized RMS amplitude as a measure of the
intensity of motor output. However, there was again no
change in RMS amplitude with the application of L-NAME
and PTIO (F[2,16]  1.8, P  0.05, n  9). These findings
indicate that endogenous NO modulates the frequency of
locomotor activity via effects on excitatory components of
the locomotor control network, while modulation of burst
amplitude likely involves inhibitory components.
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Fig. 2. Removal of endogenous NO leads to a decrease in the amplitude and increase in the frequency of the locomotor-related activity. A: raw (top) and
rectified/integrated (bottom) traces recorded from left and right L2 ventral roots showing the effect of coapplication of NOS inhibitor nitro-L-arginine methyl ester
(L-NAME; 200 M) and NO scavenger PTIO (400 M). B: time course plots of normalized data aggregated into 1-min bins show a decrease in amplitude (top)
and an increase in frequency (bottom) during coapplication of L-NAME and PTIO. C: locomotor burst amplitude (Ci) and frequency (Cii) during a 5-min period
in control, L-NAME and PTIO application, and washout (25 and 45 min from start of drug application or washout). Individual data points are shown in gray,
and mean is represented by black line. Statistically significant differences in pairwise comparisons: *P  0.05, **P  0.01, ***P  0.001; n  8. a.u., Arbitrary
unit.
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We next assessed the effects of exogenous NO on disinhib-
ited preparations. The application of 50 M DEA/NO to
disinhibited preparations caused a decrease in the frequency of
locomotor-related activity (26.5  6.2%; Fig. 6, A, B, and Cii;
F[2,20] 8.4, P 0.01, n 11), and although there appeared
to be a trend toward an increase in burst amplitude, this did not
reach statistical significance whether measured as peak-to-peak
or RMS amplitude (Fig. 6, A, B, and Ci; peak-to-peak: F[2,20] 
1.4, P  0.05, n  11; RMS: 5.1  2.8%, F[2,20]  3.4, P 
0.05, n  11). In agreement with application of 50 M
DEA/NO, 200 and 400 M DEA/NO also produced a decrease
in the frequency of locomotor-related activity (200 M: 27.5 
6.1%, F[2,12]  15.2, P  0.001, n  7; 400 M: 35.7 
11.5%, F[2,14]  5.3, P  0.05, n  8; data not shown).
However, in contrast to 50 M DEA/NO, 200 and 400 M
DEA/NO produced a decrease in RMS burst amplitude (200
M: 10.3  2.0%, F[2,12]  3.9, P  0.05, n  7; 400 M:
20.5 7.1%, F[2,14] 6.1, P 0.05, n 8; data not shown)
but no change in peak-to-peak amplitude (200 M: F[2,12] 
0.2, P  0.05, n  7; 400 M: F[2,14]  3.7, P  0.05, n 
8; data not shown).
For disinhibited preparations we again assessed whether the
magnitude of the frequency effects induced by PTIO and L-
NAME or DEA/NO were dependent on the starting frequencies of
preparations. No such relationship was found for applications of
L-NAME and PTIO. However, there was a linear relationship
between the percent reduction in frequency induced by DEA/NO
(50 M) and the control frequency (401.1, P 0.05, n
11), with slower initial burst frequencies associated with smaller
DEA/NO-induced decreases in frequency. This may suggest there
is a minimum frequency at which the already slow disinhibited
preparations can generate rhythmic output.
These findings suggest that NO modulates the frequency of
locomotor-related activity by affecting excitatory components
of CPG circuitry. In contrast, the cellular components involved
in NO-mediated modulation of the intensity of locomotor-





Fig. 3. The cGMP analog 8-bromo-cGMP mimics the effects of DEA/NO on the frequency and amplitude of locomotor-related activity. A: raw (top) and
rectified/integrated (bottom) traces recorded from left and right L2 ventral roots showing the effect of 8-bromo-cGMP (200 M). B: time course plots of
normalized data aggregated into 1-min bins show an increase in amplitude (top) and a decrease in frequency (bottom) during 8-bromo-cGMP application.
C: locomotor burst amplitude (Ci) and frequency (Cii) during a 5-min period in control, 8-bromo-cGMP application (15 min into drug application), and washout
(25 min from start of washout). Individual data points are shown in gray, and mean is represented by black line. Statistically significant differences in pairwise
comparisons: *P  0.05, **P  0.01, ***P  0.001; n  9.
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Location and development of NO sources within the murine
spinal cord. Having established that endogenous NO derived
from spinal sources modulates the activity of spinal locomotor
circuitry, we next investigated the potential sources of this NO and
their postnatal development. The distribution of NO sources
within the lumbar spinal cord was elucidated by using NADPH-
diaphorase staining to indirectly label cells expressing NOS over
the postnatal developmental period P1–P12 (Fig. 7, A and B). This
staining method has been previously shown to be selective for
NOS-positive cells within the central nervous system (CNS)
(Dawson et al. 1991; Hope et al. 1991). Staining was per-
formed in transverse sections of lumbar spinal cord obtained
from animals of four different postnatal age groups: P1–P3
(n  6), P4–P6 (n  6), P7–9 (n  6), and P10–P12 (n  9).
At each of these age groups the number of NADPH-diapho-
rase-positive cells was assessed within the ventral horn, lamina
X (proximal to the central canal), and the dorsal horn (Fig. 8)
from the first to fifth lumbar segments (L1–L5). All cell counts
were adjusted to the estimated lumbar volume for each age
group.
NADPH-diaphorase-labeled neurons with intensely stained
somata and proximal dendrites were found across all age
groups and all lumbar segments (Fig. 7, A and B). Although the
morphology and size of labeled cells varied, they were typi-
cally multipolar with somal diameters of 10–30 m (Fig. 7,
A and B). In addition to neuronal staining, the microvasculature
was also observed to exhibit positive labeling at all lumbar
levels. However, this vascular labeling was not quantified and
was excluded from further analyses, which concentrated on
neuronal sources of NO.
Perhaps most relevant to locomotor control, NADPH-diaph-
orase-positive neurons were consistently observed within the
ventral horn of the lumbar spinal cord. Labeled cells were
scattered throughout lamina VII and VIII but were rarely seen
within motoneuron pools (lamina IX), with less than one cell
per animal in lamina IX for each lumbar segment (Fig. 7, A and
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Fig. 4. Inhibition of NO-sensitive soluble guanylyl cyclase (sGC) with ODQ blocks the effect of DEA/NO on the amplitude but not frequency of
locomotor-related activity. A: raw (top) and rectified/integrated (bottom) traces recorded from left and right L2 ventral roots showing the effect of DEA/NO (200
M) in the presence of ODQ (100 M). B: time course plots of normalized data aggregated into 1-min bins show no change in amplitude (top) but a decrease
in frequency (bottom) when DEA/NO is applied in the presence of ODQ. C: locomotor burst amplitude (Ci) and frequency (Cii) during a 5-min period in control
with ODQ, DEA/NO application in the presence of ODQ (25 min into DEA/NO application), and washout with ODQ (25 min from start of washout). Individual
data points are shown in gray, and mean is represented by black line. Statistically significant differences in pairwise comparisons: *P  0.05; n  12.
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B, and Fig. 8D). Cell counts revealed a rostrocaudal gradient
of NADPH-diaphorase-positive neurons in the ventral horn,
with greater numbers of cells in rostral lumbar segments
(2[1,n  132 counts from 27 animals]  36.4, P  0.001).
Analyses across different age groups also revealed an increase
in NADPH-diaphorase-positive neurons in the ventral horn
with age (2[1,n  132 counts from 27 animals]  18.8, P 
0.001; Fig. 7, A and B, and Fig. 8A). Given that counts of
NADPH-diaphorase-positive neurons in lumbar segments 1
and 2 will include NOS-positive SPNs (Blottner and Baum-
garten 1992; Burnett et al. 1995; Dun et al. 1993; Wetts et al.
1995), the rostrocaudal gradient of counted cells may relate to
the localization of SPNs to upper lumbar segments. We there-
fore also analyzed cell counts from L3–L5, where SPNs are not
present (Anderson et al. 1989; Burnett et al. 1995). The
rostrocaudal gradient of NADPH-diaphorase-positive neurons
remained across these segments (2[1,n  78 counts from 27
animals]  10.5, P  0.01).
NADPH-diaphorase-positive cells were also found to cluster
in lamina X around the central canal of the spinal cord (Fig. 7,
A and B, and Fig. 8, B and D), an area that has also been
implicated in locomotor control (Huang et al. 2000; Zagoraiou
et al. 2009). In parallel with the ventral horn, the number of
NADPH-diaphorase-positive cells in lamina X exhibited a
rostrocaudal gradient, with more cells found in rostral seg-
ments (2[1,n  132 counts from 27 animals]  23.8, P 
0.001). However, in contrast to the ventral horn, the number of
NADPH-diaphorase-positive cells in lamina X did not change
with age (2[1,n  132 counts from 27 animals]  3.8, P 
0.05; Fig. 7, A and B, and Fig. 8B). The NADPH-diaphorase-
positive neurons counted in lamina X will also include SPNs
(Burnett et al. 1995; Dun et al. 1993; Wetts et al. 1995; Fig.
7C), which may account for the rostrocaudal gradient of
labeled cells. To investigate this further, we therefore again
analyzed lamina X cell counts from L3–L5. This analysis failed
to reveal a rostrocaudal gradient of NADPH-diaphorase-posi-











Fig. 5. During the blockade of inhibitory neurotransmission the removal of endogenous NO leads to an increase in the frequency, but no change in the amplitude,
of locomotor-related activity. A: raw (top) and rectified/integrated (bottom) traces recorded from left and right L2 ventral roots showing the effect of L-NAME
(200 M) and PTIO (400 M) in disinhibited preparations in which inhibitory neurotransmission mediated by GABA (10 M bicuculline or 60 M picrotoxin)
and glycine (1 M strychnine) has been blocked. B: time course plots of normalized data aggregated into 2-min bins show no change in amplitude (top)
and an increase in frequency (bottom) with coapplication of L-NAME and PTIO during disinhibition. C: locomotor burst amplitude (Ci) and frequency
(Cii) during a 6-min period in control, L-NAME and PTIO application (16 min into drug application), and washout (26 min from start of washout).
Individual data points are shown in gray, and mean is represented by black line. Statistically significant differences in pairwise comparisons: ***P 
0.001; n  9. a.b., Arbitrary unit.
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tive neurons across L3–L5 (2[1,n  78 counts from 27
animals]  0.38, P  0.05). Thus the gradient observed in
lamina X along the entire lumbar cord reflects the presence of
SPNs in upper lumbar segments. To demonstrate the presence
of NOS-positive interneurons among SPNs in lamina X of the
upper lumbar cord, we also performed double-fluorescence label-
ing experiments using Fluoro-Gold to retrogradely label SPNs and
NOS1 immunohistochemistry to label nitrergic neurons. Consis-
tent with previous reports (Dun et al. 1993; Miles et al. 2007;
Wetts et al. 1995), we found a population of NOS1-positive
neurons in lamina X of the upper lumbar spinal cord that are not
Fluoro-Gold labeled and are therefore not SPNs (Fig. 7C).
Finally, as reported previously (Spike et al. 1993; Valtscha-
noff et al. 1992; Wetts et al. 1995), many NADPH-diaphorase-
positive neurons were found within the dorsal horn of the
lumbar spinal cord (laminae I–IX). Data from the different
dorsal lamina were pooled together into a single group. The
numbers of NADPH-diaphorase-positive cells in the dorsal
horn did not differ between the lumbar segments (2[1,n 132
counts from 27 animals]  0.4, P  0.05) but were found to
increase with the age of animals (2[1,n  132 counts from 27
animals]  33.0, P  0.001; Fig. 7, A and B, and Fig. 8C). At
the earliest postnatal stages the number of NADPH-diapho-
rase-positive neurons in the dorsal horn was similar to that in
the ventral horn or lamina X, but by P10 the dorsal horn
contained the greatest concentration of NADPH-diaphorase-
positive neurons in the lumbar spinal cord.
In summary, our anatomical analyses revealed considerable
vascular and neuronal sources of NO within the lumbar spinal
cord, including in ventral regions where the locomotor cir-
cuitry is thought to reside and in dorsal regions that may
contribute to sensory-motor integration. Ventral NO sources
exhibited a rostrocaudal bias and, along with dorsal sources,
increased in number during postnatal development.










Fig. 6. The NO donor DEA/NO can modulate both the amplitude and frequency of rhythmic activity during blockade of inhibitory neurotransmission. A: raw (top) and
rectified/integrated (bottom) traces recorded from left and right L2 ventral roots showing the effect of 50 M DEA/NO in disinhibited preparations in which inhibitory
neurotransmission mediated by GABA (10 M bicuculline or 60 M picrotoxin) and glycine (1 M strychnine) has been blocked. B: time course plots of normalized data
aggregated into 2-min bins show a decrease in frequency during DEA/NO application during disinhibition. C: locomotor burst amplitude (Ci) and frequency (Cii) during a 6-min
period in control, DEA/NO application (24 min into drug application), and washout (26 min from start of washout). Individual data points are shown in grey, and mean is
represented by black line. Statistically significant differences in pairwise comparisons: *P  0.05; n  11.
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The results of this study demonstrate that the free radical NO
can modulate mammalian spinal locomotor control networks.
Furthermore, we have shown that endogenous NO, derived from
sources within the spinal cord, plays a role in setting the frequency
and intensity of locomotor-related rhythmic activity generated by
the mammalian spinal cord. These findings suggest that NO acts
as an intrinsic neuromodulator of both interneurons within the
locomotor CPG and motoneurons conveying the final motor












Fig. 7. Sources of NO within the lumbar spinal cord labeled
with NADPH-diaphorase staining. A and B: representative
images of transverse spinal cord sections at the level of the
3rd segment (L3) taken from postnatal day (P)3 (A) and P10
(B) animals. Microvasculature and intensely stained cells are
visible within the sections. The locations of cells shown in
images Aii–Aiv and Bii–Biv (insets) are indicated with filled,
open, and shaded arrowheads, respectively. Insets show pos-
itively stained cells in the dorsal horn (ii) and ventral horn
(iii) and proximal to the central canal (iv). C: fluorescence
images of a transverse spinal cord section (50-m thickness,
L1 level, P6 CD1 mouse) centered on the central canal (cc)
showing immunohistochemical labeling using antibodies
raised against NOS1 (Ci) and retrograde labeling of sympa-
thetic preganglionic neurons (SPNs) with Fluoro-Gold (Cii).
Merged image (Ciii) shows NOS1-positive SPNs (purple
arrowheads) and non-SPN NOS1-positive cells (blue arrow-
heads). Scale bars: 500 m in Ai and Bi; 20 m in Aii–Aiv,
Bii–Biv, and Ci–Ciii.
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The addition of exogenous NO, via the NO donor DEA/NO,
to isolated mouse spinal cord preparations during stable phar-
macologically induced locomotor activity was shown to con-
sistently reduce the frequency of locomotor-related rhythmic
activity in a concentration-dependent manner. This change in
frequency was associated with no change in burst duration but
a decrease in duty cycle at higher concentrations of DEA/NO. The
lack of a significant change in duty cycle with low concentrations
of DEA/NO may relate to the relatively small change in frequency
these concentrations induce. Interestingly, constant L2 (flexor
related) burst durations along with decreases in duty cycle may
relate to whole animal studies showing that during changes in
locomotor speed the flexor (swing) phase remains relatively
constant while the extensor (stance) phase is altered (Pearson
1976).
In contrast to the effects on frequency, the polarity of the
effects of exogenous NO on the amplitude of locomotor-related
activity was concentration dependent, with lower concentra-
tions of DEA/NO increasing and high concentrations decreas-
ing the amplitude of locomotor-related output. These results
are analogous to previous studies showing opposing, concen-
tration-dependent effects of exogenous NO on neurotransmitter
release (Prast et al. 1998) and neuronal firing (Pierrefiche et al.
2007) and suggest that NO-mediated signaling might in some
circumstances change the nature of motor output rather than
simply fine-tuning it. Given reports that reductions in locomo-
tor frequency are associated with increases in the amplitude of
locomotor-related output (e.g., Barriere et al. 2004), it might be
argued that the increase in amplitude we observed with low
concentration of DEA/NO reflects some underlying inverse
correlation between these two parameters. In opposition to this,
we report a sustained increase in amplitude despite the loco-
motor frequency returning to control levels following drug
washout (Fig. 1Ci). Furthermore, several studies have demon-
strated that modulation of locomotor-related frequency does
not necessarily coincide with changes in amplitude, and vice
versa (e.g., Kiehn et al. 1999; Sqalli-Houssaini and Cazalets
2000; Witts et al. 2012).
Removal of endogenous NO, via the blockade of NOS and
















































































































Fig. 8. Distribution of NADPH-diaphorase-stained cells within the lumbar spinal cord. NADPH-diaphorase-positive cells were counted in the ventral horn (A),
lamina X (B), and dorsal horn (C) of each lumbar segment (L1–L5) in animals across 4 different age groups (P1–P3, P4–P6, P7–P9, and P10–12; n 6–9 animals
per age group). In individual animals, cells were counted from 5 nonconsecutive sections from each lumbar segment. Counts were then averaged across animals
and reported relative to lumbar spinal cord volume. A: distribution of NADPH-diaphorase-positive cells in the ventral horn displayed a rostrocaudal gradient,
with more cells in rostral compared with caudal segments. In addition, the number of labeled cells in the ventral horn increased with age. B: NADPH-diaphorase-
positive cells in lamina X also showed a rostrocaudal gradient, with a greater number of cells in rostral segments, while no significant developmental changes
were observed. C: in the dorsal horn, NADPH-diaphorase-positive cells were evenly distributed along the rostrocaudal axis and increased in number with age.
D: diagrams showing the positions of positively stained cells across 5 NADPH-diaphorase-stained sections at each lumbar segment (L1–L5) and across all age
groups (P1–P3, P4–P6, P7–P9, and P10–P12). Sections and diagrams are orientated with the dorsal side at top, and the outlines represent the gray-white matter
border.
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amplitude of locomotor-related output. These data demonstrate
that NO is not just a potential modulator of spinal motor
circuitry but endogenously derived NO actually influences
locomotor control circuitry during ongoing activity. Although
analyses of NOS1 (Nelson et al. 1995)- and sGC (Schmidtko et
al. 2008)-knockout mice have revealed no overt changes in
gross motor activity, it would be interesting to investigate
potential deficits in their ability to modulate motor output (e.g.,
swim vs. walking tasks; Zagoraiou et al. 2009). The recent
creation of NOS1-Cre mouse lines (Taniguchi et al. 2011) may
also facilitate more direct investigations of the roles of NOS1-
positive interneurons in locomotor control. In our study the
effects of blockade of NO-mediated signaling were found to be
opposite to the effects of application of low concentrations of
exogenous NO (50 M DEA/NO). Thus lower concentrations
of exogenous NO most likely demonstrate the endogenous,
physiological roles of NO in motor control circuitry. In con-
trast, the effects of higher concentrations of the NO donor may
represent nonphysiological or possibly pathophysiological
conditions. Interestingly, increased expression of NOS iso-
forms has been implicated in pathological conditions such as
amyotrophic lateral sclerosis (Catania et al. 2001; Phul et al.
2000) and arthritis-induced hyperalgesia (Wu et al. 1998).
The demonstration that NO acts as an intrinsic modulator of
spinal locomotor control circuitry in mice parallels previous
investigations of locomotor circuitry in aquatic vertebrates
(Kyriakatos et al. 2009; Kyriakatos and El Manira 2007;
McLean and Sillar 2000, 2004) and respiratory control cir-
cuitry in rodents (Mironov and Langohr 2007; Pierrefiche et al.
2007). Our findings are most similar to those of previous
studies in the Xenopus tadpole, in which NO was found to act
in an inhibitory manner, slowing the frequency of activity
produced by the locomotor CPG (McLean and Sillar 2000).
Interestingly, in the pro-metamorphic Xenopus (Sillar et al.
2008) and adult lamprey (Kyriakatos et al. 2009; Kyriakatos
and El Manira 2007) the intrinsic neuromodulatory effects of
NO are opposite to those observed in the Xenopus tadpole, with
NO-mediated signaling leading to an increase in the frequency
of locomotor activity at later stages. These data support, at least
in Xenopus, a developmental reversal in the role of NO in
locomotor control that might relate to changes in locomotor
function due to metamorphosis. Whether similar developmen-
tal changes might alter the nature of the modulatory effect of
NO on mouse locomotor circuitry remains to be determined,
although one might predict more subtle changes than those
observed in the metamorphic Xenopus.
In the Xenopus tadpole the inhibitory effect of NO on
locomotor frequency results largely from its facilitation of
GABAergic and glycinergic transmission (McLean and Sillar
2002, 2004), while in the lamprey NO-mediated facilitation of
locomotor frequency involves modulation of both inhibitory
and excitatory transmission (Kyriakatos et al. 2009). Our data,
demonstrating that NO-mediated modulation of the frequency
of motor activity persists when inhibition is blocked, suggest
that the effects of NO on motor activity generated by the mouse
spinal cord involve modulation of excitatory rather than inhib-
itory components of spinal motor circuitry. In contrast, the
effects of endogenous NO on the intensity of motor output
generated by the mouse spinal cord may involve inhibitory
components of the network, since blockade of NO-mediated
signaling no longer affects the amplitude of motor bursts when
inhibition is also blocked. Interestingly, exogenous NO can
still modulate the amplitude of motor activity in the absence of
inhibition. This suggests that the intensity of motor output can
also be modulated by mechanisms involving inhibitory com-
ponents of spinal motor circuitry but that under our experimen-
tal conditions such mechanisms are unlikely to be engaged by
NO derived from spinal sources. When interpreting data from
disinhibited preparations it should be noted that, although
indirect evidence supports involvement of common motor
circuitry in the generation of disinhibited bursting and fictive
locomotor activity (Bracci et al. 1996; Kiehn 2006), it remains
unknown whether the same populations of neurons underlie
these two rhythmic outputs. Further analyses at the cellular
level will therefore be required to elucidate the exact compo-
nents of the spinal motor circuitry that are modulated by
NO-mediated signaling.
The main target for NO is sGC, which is widely expressed
throughout the mouse lumbar spinal cord (Schmidtko et al.
2008), and the subsequent activation of cGMP-dependent path-
ways. Utilizing a membrane-permeant cGMP analog, 8-bromo-
cGMP, we have demonstrated that the sGC system can mod-
ulate both the amplitude and frequency of locomotor-related
output generated by the mouse spinal cord. The effects of
8-bromo-cGMP mimic those of low concentrations of an NO
donor (50 M DEA/NO). In addition, inhibition of sGC with
ODQ was found to block NO-mediated modulation of loco-
motor burst amplitude. These data are consistent with NO
modulating motoneurons, and/or the synaptic inputs they re-
ceive, via sGC/cGMP-dependent pathways, as has previously
been demonstrated in brain stem motoneurons (Abudara et al.
2002; Mironov and Langohr 2007; Montero et al. 2008; Wen-
ker et al. 2012). In contrast, ODQ blocked the modulation of
locomotor burst frequency mediated by low but not high
concentrations of DEA/NO. These data suggest involvement of
sGC/cGMP-dependent and potentially additional signaling
pathways, such as those involving S-nitrosylation of proteins
(Ahern et al. 2002), in NO-mediated modulation of rhythm-
generating components of the murine locomotor circuitry.
Although the concentration of ODQ used in this investigation
is equal to or higher than that used in previous studies (Kyri-
akatos et al. 2009; Kyriakatos and El Manira 2007; Mironov
and Langohr 2007; Pierrefiche et al. 2007), it is still possible
that we were unable to fully block sGC with ODQ. However,
higher concentrations of ODQ (up to 400 M) could not be
used because they were found to disrupt the pharmacologically
induced rhythm. This may further support the importance of
NO-mediated signaling in locomotor control, although the
potential for off-target effects of ODQ at high concentrations
cannot be discounted.
Along with acute effects on locomotor-related activity, ap-
plications of NO donor at lower concentrations (50 M DEA/
NO) or 8-bromo-cGMP to the isolated spinal cord led to a
sustained increase in the amplitude of locomotor-related activ-
ity. These long-lasting effects, which extended into the wash-
out period and remained as long as stable rhythms could be
recorded, may represent an LTP-type effect of NO on the
locomotor control network. Similar effects were also seen
during an extended washout of L-NAME and PTIO, which may
result from a rebound in endogenous NO levels following
removal of blockers/scavengers. NO-mediated signaling is
known to contribute to LTP of glutamatergic synapses in the
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hippocampus (Garthwaite and Boulton 1995; Prast and
Philippu 2001) and, more recently, GABAergic synapses in
lamina I of the spinal dorsal horn (Fenselau et al. 2011). In
addition, and perhaps most relevant to the present study, NO is
involved in the LTP of locomotor frequency evoked by acti-
vation of metabotropic glutamate receptor 1 in the lamprey
spinal cord (Kyriakatos and El Manira 2007). Our findings,
indicating an LTP-like effect on the amplitude of locomotor-
related activity, may demonstrate a novel plastic effect of NO
on components of the mammalian locomotor system. It will be
important to investigate the cellular mechanisms of this plas-
ticity in future studies.
In addition to examining the physiological effects of NO-
mediated signaling on spinal motor circuitry, we also investi-
gated spinal sources of NO and their postnatal development by
using the NADPH-diaphorase labeling technique. The pat-
tern of NOS-positive neurons demonstrated in this investi-
gation are in agreement with those shown previously in the
adult rat with NADPH-diaphorase histochemistry (Spike et
al. 1993; Valtschanoff et al. 1992; Wetts et al. 1995) and
NOS immunohistochemistry (Burnett et al. 1995; Dun et al.
1993). Given the localization of the locomotor CPG to the
ventral horn of the spinal cord (Cazalets et al. 1995; Kjaerulff
and Kiehn 1996), NOS-positive neurons found scattered
throughout most of the ventral horn are well-positioned to
contribute to NO-mediated modulation of locomotor activity.
NOS-positive cells in lamina X surrounding the central canal
of the spinal cord may also contribute, since neurons within
this region appear to play a role in the control of locomotion
(Huang et al. 2000; Zagoraiou et al. 2009). Previous investi-
gations have demonstrated that NO donors alter the frequency
of tonic-firing lamina X interneurons in slices from rat lumbar
spinal cord (Pehl and Schmid 1997), further supporting the
potential importance of NO production and release in this area.
In addition, given the influence of NO-mediated signaling on
sensory processing, particularly nociceptive (Freire et al.
2009), it is also possible that NOS-positive neurons within the
dorsal horn influence locomotor output via pathways involved
in sensory-motor integration.
In agreement with developmental findings in the rat lumbar
spinal cord (Wetts et al. 1995), we found that the numbers of
NOS-positive neurons within both the dorsal and ventral horns
of the mouse spinal cord increase during postnatal develop-
ment. In contrast, the number of positive cells surrounding the
central canal remains relatively static during this period of
development. Interestingly, the time course of this increase
in the number of NO sources follows the time period over
which mice progress from crawling to walking freely with
the ventral surface of the body off the ground (approxi-
mately P10; Jiang et al. 1999). Our investigation also
demonstrated a rostrocaudal bias in the distribution of the
NOS-positive neurons in the ventral horn and lamina X of
the lumbar spinal cord. These findings parallel the reported
rostrocaudal bias of the locomotor CPG to upper lumbar
segments (Cazalets et al. 1995; Kjaerulff and Kiehn 1996)
and provide further, albeit indirect, evidence linking NOS-
positive neurons to the locomotor CPG.
In agreement with previous studies (Dun et al. 1993; Spike
et al. 1993; Valtschanoff et al. 1992), we find very few NO
sources within or immediately adjacent to motoneuron pools.
However, we have demonstrated that removal of intrinsic NO
alters motor output in a manner consistent with modulation of
motoneurons or last-order synaptic inputs they receive (Miles
and Sillar 2011). Other physiological investigations have
shown NO to alter the excitability of trigeminal (Abudara et al.
2002) and hypoglossal (Montero et al. 2008) motoneurons and
modulate both inhibitory and excitatory synaptic inputs to the
motoneurons (Abudara et al. 2002; Kyriakatos et al. 2009).
While NO can act as a volume transmitter, with a sphere of
influence based on diffusion in CNS tissue of20 m from its
source (Steinert et al. 2008), the lack of labeled cell bodies
within or near motoneuron pools may indicate that local
interneurons are not the primary source of the NO affecting
motoneurons. However, given that NO may be released from
dendrites or NOS-positive synaptic terminals, which have been
reported within motor pools (Miles et al. 2007), the influence
of NOS-positive interneurons may be farther reaching than the
location of their cell bodies suggests. Alternatively, in parallel
with findings in the hippocampus, where basal levels of NO
provided by the vasculature are known to be required for LTP
(Hopper and Garthwaite 2006; O’Dell et al. 1994; Son et al.
1996), it is possible that the endogenous NO that modulates
locomotor-related output arises from the microvasculature of
the spinal cord. At present there is a lack of selective NOS3
inhibitors (Boer et al. 2000), limiting our ability to directly
investigate the contribution of vascular sources of NO.
In summary, we have demonstrated that endogenous NO,
derived from sources within the developing mouse spinal cord,
modulates locomotor-related output produced by spinal motor
circuitry. At concentrations we speculate are most physiolog-
ically relevant, NO-mediated modulation includes long-term
changes to the intensity of locomotor-related output. Mean-
while, experiments investigating the effects of higher, possibly
pathological, concentrations of NO highlight potentially dele-
terious inhibitory effects this modulator may have on motor
output. While advancing our understanding of the neuro-
modulatory control of spinal motor networks, this study also
provides a platform from which to investigate the influences
of NO at the cellular level. Such work is not only important
for further advancement of our basic understanding of motor
control but may also highlight pathways that can be targeted
for the treatment of injury and disease affecting the spinal
cord.
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